OPRK1 and non-small cell lung carcinoma: Their receptors, mainly classic opioid receptors including mu (μ), delta (δ), and kappa (κ) (MOR, DOR, and KOR) have been reported to be expressed in NSCLC cell lines or in tumor tissues, and they perform different functions correlated with the clinical prognosis.